Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.
Avinger, Inc. (NASDAQ: AVGR) gained 63.9% to $9.95, adding to outsized gains from Monday. On Monday, Avinger shares soared 46.8% after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.
Sezzle Inc. (NASDAQ: SEZL) shares climbed 46.6% to $18.95.
PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) rose 30% to $5.17.
Elutia Inc. (NASDAQ: ELUT) shares gained 29.1% to $1.6006 after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics LLC. Elutia announced $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share.
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) surged 24.4% to $10.50. The FDA granted an investigational device exemption to initiate BACKBEAT Study evaluating Orchestra biomed's atrioventricular interval modulation therapy (BACKBEAT CNT) for hypertensive patients who are indicated for a dual-chamber cardiac pacemaker.
Rackspace Technology, Inc. (NASDAQ: RXT) gained 20.2% to $1.78 after Raymond James upgraded the stock from Market Perform to Outperform and announced a $3.5 price target.
Eos Energy Enterprises, Inc. (NASDAQ: EOSE) jumped 16.6% to $2.65.
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) rose 15% to $5.32 after falling 18% on Monday. Neptune Wellness announced intention to spinout Sprout Organics pursuant to the Morgan Stanley agreed to transaction.
Solowin Holdings (NASDAQ: SWIN) climbed 14.8% to $2.3882.
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) gained 13.5% to $0.1048.
Galera Therapeutics, Inc. (NASDAQ: GRTX) shares rose 13.2% to $0.2158. Galera scheduled a Type A meeting with the FDA to discuss next steps for its radiotherapy avasopasem.
Lichen China Limited (NASDAQ: LICN) gained 11.6% to $1.15.
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) jumped 11.4% to $5.85.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) gained 10% to $9.48.
SelectQuote, Inc. (NYSE: SLQT) rose 9.6% to $1.2395. Selectquote COO William Grant, III reported purchase of 150,000 shares at an average price of $1.20 per share in Form 4 filing on Monday.
Conduent Incorporated (NASDAQ: CNDT) gained 9.4% to $3.3703. Conduent and HealthEquity announced that they have entered into a definitive agreement to transfer BenefitWallet's Health Savings Account (HSA) portfolio to HealthEquity.
Stem, Inc. (NYSE: STEM) gained 8.6% to $4.88. Stem expanded its India Center Of Excellence, aimed at fostering global growth, optimizing operations, and increasing customer value.
Waldencast plc (NASDAQ: WALD) jumped 7.3% to $9.41.
Semtech Corporation (NASDAQ: SMTC) gained 5% to $25.48. Semtech Director Paul V. Walsh Jr. acquired a total of 20,000 shares at an average price of $24.83.
Losers
Digital Transformation Opportunities Corp. (NASDAQ: DTOC) shares fell 34.5% to $19.00 after jumping 173% on Monday.
Histogen Inc. (NASDAQ: HSTO) fell 32.9% to $0.4419 as the company reported board approval of complete liquidation and dissolution.
Revance Therapeutics, Inc. (NASDAQ: RVNC) declined 26% to $12.27 after the company issued corporate update at Investor Day. Revance Therapeutics estimates total non-cash impairment charges from goodwill and other assets to be between an estimated $80 million and $100 million.
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares fell 26% to $0.2517 after declining 15% on Monday.
Axcella Health Inc. (NASDAQ: AXLA) declined 24.5% to $11.32.
MSP Recovery, Inc. (NASDAQ: LIFW) fell 23.8% to $0.0931 after dipping 35% on Monday.
Terran Orbital Corporation (NYSE: LLAP) fell 19.4% to $1.1450 after the company priced its previously announced public offering of 23.2 million shares and warrants to purchase up to 23.2 million shares at a combined public offering price of $1.40 per share and accompanying warrant.
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares fell 18.9% to $0.90 after the company said it has withdrawn its COVID Phase IIB investigational new drug and announced plans to resubmit pending assessment of ability to meet FDA requirements.
SCWorx Corp. (NASDAQ: WORX) fell 18.5% to $0.2130 after jumping 38% on Monday.
T2 Biosystems, Inc. (NASDAQ: TTOO) fell 17.4% to $0.3796. T2 Biosystems shares gained over 65% on Monday after the FDA cleared the company's biothreat panel for commercial distribution.
Equinox Gold Corp. (NYSE: EQX) shares slipped 17% to $4.3499 after the company reported a bought deal offering of convertible senior notes.
Perspective Therapeutics, Inc. (NASDAQ: CATX) fell 15.2% to $0.2711 after jumping 56% on Monday.
Ebix, Inc. (NASDAQ: EBIX) fell 14% to $11.27.
Aurora Innovation, Inc. (NASDAQ: AUR) declined 13.6% to $3.0670. TD Cowen initiated coverage on Aurora Innovation with a Market Perform rating and announced a price target of $3.
Amprius Technologies, Inc. (NYSE: AMPX) fell 11.2% to $4.4650. The company announced it will showcase its new silicon nanowire battery manufacturing line on Dec. 14.
Cardlytics, Inc. (NASDAQ: CDLX) declined 10.9% to $14.56.
NIO Inc. (NYSE: NIO) shares fell 10.4% to $9.23 after the company announced a proposed offering of $1 billion convertible senior notes.
ProKidney Corp. (NASDAQ: PROK) dipped 10.3% to $5.77.
Vasta Platform Limited (NASDAQ: VSTA) fell 9.9% to $3.5767.
TuSimple Holdings Inc. (NASDAQ: TSP) fell 9.7% to $1.4526.
Rocket Lab USA, Inc. (NASDAQ: RKLB) shares fell 9.2% to $4.5775 as the company's 41st mission succumbs to technical issues, prompting it to postpone its next mission and revise its third-quarter guidance.
Carvana Co. (NYSE: CVNA) declined 8.5% to $47.53.
Nanobiotix S.A. (NASDAQ: NBTX) fell 7.6% to $8.36.
Arm Holdings plc (NASDAQ: ARM) fell 5% to $55.08 amid post-IPO volatility. Redburn Atlantic initiated coverage on the stock with a Neutral rating and a $50 price target.
Now Read This: Wall Street's Most Accurate Analysts Say Buy These 3 Tech Stocks With Over 3% Dividend Yields
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.